跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,288 条关于
“Chia Tai-Tianqing Pharmaceutical”
全部
21,288
临床试验
5,936
药物
2,451
机构
2,327
资讯
10,574
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease
去年
Algeria Approves Sino Biopharmaceutical's Adalimumab Biosimilar for Autoimmune Disease Treatment
5个月前
SBP Group's M701 Bispecific Antibody Receives NDA Acceptance for Malignant Ascites Treatment
去年
Inventiva Restructures: Halves Workforce to Focus on Late-Stage MASH Drug Lanifibranor
去年
Inventiva Secures €348 Million to Advance Lanifibranor Phase III Trial for MASH
去年
Hemophilia A and B Pipeline Advances with Novel Therapies in Clinical Trials
2年前
Anlotinib and Penpulimab Combination Shows Promise in Advanced Hepatocellular Carcinoma
2年前
Anlotinib and Penpulimab Combination Shows Promise in First-Line HCC Treatment
6个月前
Sino Biopharmaceutical Receives NMPA Approval for Pan-KRAS Inhibitor TQB3205 Clinical Trial
去年
Advanced Renal Cell Carcinoma Pipeline Shows Strong Growth with 60+ Therapies in Development
第 1 页，共 1058 页
上一页
下一页
